Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving the way for better treatments for autoimmune diseases and cancer immunotherapy. ADAR1 ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...
MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...
News Medical on MSN
Small nuclear RNA base editing a safer alternative to CRISPR, UC San Diego researchers find
Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...
(A) Design of 10 crRNAs matching Ctnnb1 or Smo transcripts. (B) Schematic of Ctnnb1 or Smo knockdown by CRISPR/CasRx. The sequences of the crRNA spacer are complementary to the Ctnnb1 or Smo ...
Eli Lilly And Co (NYSE:LLY) on Thursday entered into a strategic global research collaboration and licensing agreement with Rznomics Inc., a South Korea-based biopharmaceutical company specializing in ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than good. A new study from University of California San Diego and Yale ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback